| Name | Setipiprant | CAS# | 866460-33-5 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Setipiprant is an orally available, selective CRTH2 antagonist. CRTH2 is a G protein-coupled receptor for PGD2. |
Get all suppliers by the below link:
| 2024-07-15 |
2-(2-(1-Naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)aceticacid
Price: Inquiry |
| 2020-01-06 |
Setipiprant(ACT129968)
Price: $450.0 |
| 2021-07-26 |
2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid
Price: $Inquiry |
| 2018-03-01 |
Setipiprant
Price: ¥100.0 |
| 2023-09-26 |
Setipiprant
Price: ¥Inquiry |
| 2018-02-11 |
ACT-129968
Price: ¥Inquiry |
| 2017-08-07 |
Setipiprant
Price: ¥Inquiry |
| 2017-11-19 |
2-(2-(1-Naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid
Price: ¥Inquiry |
| 2024-05-23 |
Setipiprant
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


